Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
EBIT Growth

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -14.6481.56139.20-22.3865.42

What is the latest EBIT Growth ratio of NEULAND LABORATORIES ?

The latest EBIT Growth ratio of NEULAND LABORATORIES is -14.64 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-14.64
Mar202481.56
Mar2023139.20
Mar2022-22.38
Mar202165.42

How is EBIT Growth of NEULAND LABORATORIES Trending?

Years EBIT Growth % Change
Mar2025 -14.64
Negative
Mar2024 81.56
-41.41
Mar2023 139.2
Positive
Mar2022 -22.38
Negative
Mar2021 65.42 -

Other Financial Ratios of NEULAND LABORATORIES


Compare EBIT Growth ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹15,399.7 Cr -3% -4.9% 0.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,555.0 Cr -1.5% 1.6% 1.3% Stock Analytics
DIVIS LABORATORIES ₹159,889.0 Cr -2% -4.3% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,073.0 Cr -0.8% 0.5% 32% Stock Analytics
DR REDDYS LABORATORIES ₹105,133.0 Cr -2.7% -1.6% 6.9% Stock Analytics
CIPLA ₹98,492.9 Cr -3.9% -9.1% -18.4% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-3%

-4.9%

0.3%

SENSEX

-2.6%

-10.2%

-1.6%


You may also like the below Video Courses